Common Criteria for Ex Vivo Lung Perfusion Have No Significant Impact on Posttransplant Outcomes
نویسندگان
چکیده
BackgroundAlthough it is intense in health care resources, by facilitating assessment and reconditioning, ex vivo lung perfusion (EVLP) has the potential to expand donor pool improve transplant outcomes. However, inclusion criteria used EVLP trials have not been validated.MethodsThis retrospective study from 2014 2018 reviewed our local state-based donation organization records as well subsequent recipient outcomes explore relation between indications clinical The primary outcome was graft dysfunction grade 3 at 24 hours, with 30-day mortality posttransplant survival time secondary outcomes, compared univariate multivariate analysis.ResultsFrom 705 referrals, 304 transplantations were performed (use rate of 42%); 212 recipients (70%) met least 1 commonly cited initiation criteria. There no significant difference or without an indication (10.2% versus 7.8%, P = .51; 2.4% 0%, .14, respectively). Multivariate analyses showed relationship time. Recipient significantly associated diagnosis.ConclusionsAt criterion for present 70% transplanted donors, yet did predict results; acceptable seen both subgroups. To discover true utility beyond good management focus on otherwise unacceptable lungs, a reconsideration required. Although validated. This analysis. From diagnosis. At
منابع مشابه
Ex vivo lung perfusion in Brazil
OBJECTIVE To evaluate the use of ex vivo lung perfusion (EVLP) clinically to prepare donor lungs for transplantation. METHODS A prospective study involving EVLP for the reconditioning of extended-criteria donor lungs, the criteria for which include aspects such as a PaO2/FiO2 ratio < 300 mmHg. Between February of 2013 and February of 2014, the lungs of five donors were submitted to EVLP for u...
متن کاملEx vivo lung perfusion: initial Brazilian experience* Perfusão pulmonar ex vivo: experiência nacional inicial
In the last 20 years, lung transplantation has become the standard treatment for patients with end-stage lung disease. However, less than 20% of the donor lungs available for transplant are actually usable. This disparity between the growing number of recipients and the small number of donors has resulted in increased mortality among lung transplant candidates on waiting lists. Strategies such ...
متن کاملAntagonizing reactive oxygen species during ex vivo lung perfusion.
TO THE EDITOR: The stop of flow (ischemia) would be interpreted as membrane depolarization, through the inhibition of KATP channels, leading to activation of NADPH oxidase, leading to increased reactive oxygen species (ROS) production (1). The resultant ROS are claimed to be an effective mediator for ischemic preconditioning (IPC), as proved by the observation that the presence of antioxidants ...
متن کاملTowards a better understanding of ex vivo lung perfusion.
Ex vivo lung perfusion (EVLP) is probably the most promising technique currently available to substantially increase the number of acceptable donor lungs and to improve the outcome after lung transplantation. Several ongoing prospective single and multicentre trials are currently investigating the potential and the individual advantages of different platforms available for EVLP. So far, a numbe...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Annals of Thoracic Surgery
سال: 2021
ISSN: ['1552-6259', '0003-4975']
DOI: https://doi.org/10.1016/j.athoracsur.2020.06.081